These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 14973540)
41. Efficient intracellular retrotransposition of an exogenous primate retrovirus genome. Heinkelein M; Pietschmann T; Jármy G; Dressler M; Imrich H; Thurow J; Lindemann D; Bock M; Moebes A; Roy J; Herchenröder O; Rethwilm A EMBO J; 2000 Jul; 19(13):3436-45. PubMed ID: 10880456 [TBL] [Abstract][Full Text] [Related]
42. Gibbon ape leukemia virus poorly replicates in primary human T lymphocytes: implications for safety testing of primary human T lymphocytes transduced with GALV-pseudotyped vectors. Lamers CH; Willemsen RA; van Elzakker PM; Gratama JW; Debets R J Immunother; 2009 Apr; 32(3):272-9. PubMed ID: 19242373 [TBL] [Abstract][Full Text] [Related]
44. Lentiviral transduction of human hematopoietic cells by HIV-1- and SIV-based vectors containing a bicistronic cassette driven by various internal promoters. Dupuy FP; Mouly E; Mesel-Lemoine M; Morel C; Abriol J; Cherai M; Baillou C; Nègre D; Cosset FL; Klatzmann D; Lemoine FM J Gene Med; 2005 Sep; 7(9):1158-71. PubMed ID: 15880619 [TBL] [Abstract][Full Text] [Related]
45. Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells. Schambach A; Bohne J; Chandra S; Will E; Margison GP; Williams DA; Baum C Mol Ther; 2006 Feb; 13(2):391-400. PubMed ID: 16226060 [TBL] [Abstract][Full Text] [Related]
46. Stable inhibition of hepatitis B virus proteins by small interfering RNA expressed from viral vectors. Moore MD; McGarvey MJ; Russell RA; Cullen BR; McClure MO J Gene Med; 2005 Jul; 7(7):918-25. PubMed ID: 15756649 [TBL] [Abstract][Full Text] [Related]
47. A minimal genome simian foamy virus type 1 vector system with efficient gene transfer. Park J; Nadeau PE; Mergia A Virology; 2002 Oct; 302(2):236-44. PubMed ID: 12441068 [TBL] [Abstract][Full Text] [Related]
48. Inhibition of simian immunodeficiency virus by foamy virus vectors expressing siRNAs. Park J; Nadeau P; Zucali JR; Johnson CM; Mergia A Virology; 2005 Dec; 343(2):275-82. PubMed ID: 16181654 [TBL] [Abstract][Full Text] [Related]
49. A HIV-2-based self-inactivating vector for enhanced gene transduction. Mukherjee S; Lee HL; Pacchia AL; Ron Y; Dougherty JP J Biotechnol; 2007 Jan; 127(4):745-57. PubMed ID: 16979253 [TBL] [Abstract][Full Text] [Related]
50. Optimization of adenovirus serotype 35 vectors for efficient transduction in human hematopoietic progenitors: comparison of promoter activities. Sakurai F; Kawabata K; Yamaguchi T; Hayakawa T; Mizuguchi H Gene Ther; 2005 Oct; 12(19):1424-33. PubMed ID: 15944730 [TBL] [Abstract][Full Text] [Related]
51. Effects of viral strain, transgene position, and target cell type on replication kinetics, genomic stability, and transgene expression of replication-competent murine leukemia virus-based vectors. Paar M; Schwab S; Rosenfellner D; Salmons B; Günzburg WH; Renner M; Portsmouth D J Virol; 2007 Jul; 81(13):6973-83. PubMed ID: 17442710 [TBL] [Abstract][Full Text] [Related]
52. A novel self-deleting retroviral vector carrying an additional sequence recognized by the viral integrase (IN). Torne-Celer C; Moreau K; Faure C; Chebloune Y; Verdier G; Ronfort C Virus Res; 2008 Jul; 135(1):72-82. PubMed ID: 18420298 [TBL] [Abstract][Full Text] [Related]
53. A convenient method for positive selection of retroviral producing cells generating vectors devoid of selectable markers. Xu L; Tsuji K; Mostowski H; Otsu M; Candotti F; Rosenberg AS J Virol Methods; 2004 Jun; 118(1):61-7. PubMed ID: 15158069 [TBL] [Abstract][Full Text] [Related]
54. Gene transfer system derived from the caprine arthritis-encephalitis lentivirus. Mselli-Lakhal L; Guiguen F; Greenland T; Mornex JF; Chebloune Y J Virol Methods; 2006 Sep; 136(1-2):177-84. PubMed ID: 16797087 [TBL] [Abstract][Full Text] [Related]
55. Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors. Trobridge G; Russell DW J Virol; 2004 Mar; 78(5):2327-35. PubMed ID: 14963129 [TBL] [Abstract][Full Text] [Related]
56. [Production of avian infectious bursitis virus by in vivo DNA genomic transcription]. Mardassi H; Arfaoui A; Gribaa L; Ghram A Arch Inst Pasteur Tunis; 2000; 77(1-4):59-65. PubMed ID: 14658230 [TBL] [Abstract][Full Text] [Related]
57. Foamy virus replication: implications for interaction with other retroviruses and host cellular sequences. Linial ML Dev Biol (Basel); 2001; 106():231-6; discussion 253-63. PubMed ID: 11761236 [TBL] [Abstract][Full Text] [Related]
58. Complex effects of foamy virus central purine-rich regions on viral replication. Peters K; Barg N; Gärtner K; Rethwilm A Virology; 2008 Mar; 373(1):51-60. PubMed ID: 18078974 [TBL] [Abstract][Full Text] [Related]
59. Inhibition of hepatitis B virus replication in 2.2.15 cells by expressed shRNA. Ren XR; Zhou LJ; Luo GB; Lin B; Xu A J Viral Hepat; 2005 May; 12(3):236-42. PubMed ID: 15850463 [TBL] [Abstract][Full Text] [Related]
60. Isolation and sequencing of infectious clones of feline foamy virus and a human/feline foamy virus Env chimera. Hatama S; Otake K; Omoto S; Murase Y; Ikemoto A; Mochizuki M; Takahashi E; Okuyama H; Fujii Y J Gen Virol; 2001 Dec; 82(Pt 12):2999-3004. PubMed ID: 11714976 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]